Author

Christine J. Pak

Brigham and Women's Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alyssa C. BouskaiD· 1 shared Andreas RosenwaldiD· 1 shared Andrew J. GentlesiD· 1 shared Ash A. AlizadehiD· 1 shared Chih Long LiuiD· 1 shared Dalia Y. MooreiD· 1 shared Dhiraj KumariD· 1 shared Elena HartmanniD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alyssa C. BouskaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in the activated B-cell subtype of diffuse large B-cell lymphoma

Neeraj Kumar Jain, Keenan T. Hartert, Saber Tadros, Warren C. Fiskus, Ondřej Havránek, Man Chun John Ma, Alyssa C. Bouska, Tayla B. Heavican, Dhiraj Kumar, Qing Deng, Dalia Y. Moore, Christine J. Pak, Chih Long Liu, Andrew J. Gentles, Elena Hartmann, , Michael R. Green

The paper identifies TCF4 overexpression driven by 18q21.2 gains as a mechanism promoting IgM expression in ABC-like DLBCL and shows BET inhibitors can suppress it.

Science Translational Medicine · Jun 19, 2019Peer-reviewedGenomics